Chronic benzodiazepine treatment decreases postsynaptic GABA sensitivity

Area of Science:

• Neuropharmacology
• Neuroscience
• Molecular Biology

Background:

• Benzodiazepines are commonly prescribed for anxiety and sleep disorders.
• Clinical observations suggest reduced effectiveness of benzodiazepines with prolonged use.
• The precise mechanisms underlying this diminished drug response remain incompletely understood.

Purpose of the Study:

• To investigate the electrophysiological basis for reduced response to chronic benzodiazepine administration.
• To examine changes in postsynaptic sensitivity to gamma-aminobutyric acid (GABA) in the brain.
• To assess the role of benzodiazepine receptors in mediating these adaptations.

Main Methods:

• Electrophysiological recordings using direct iontophoretic application of GABA and serotonin.
• Experiments conducted on serotonergic cells in the midbrain dorsal raphe nucleus (DRN) of rodents.
• Radioligand-binding assays to evaluate benzodiazepine receptor characteristics.
• Administration of diazepam for extended periods (three weeks or longer) and acute administration of Ro15-1788 (benzodiazepine antagonist).

Main Results:

• Chronic diazepam administration led to a dose-dependent decrease in postsynaptic sensitivity to GABA.
• This subsensitivity to GABA was observed in animals treated for three weeks or longer.
• The benzodiazepine antagonist Ro15-1788 rapidly reversed the decreased GABA sensitivity in chronically treated animals.
• Radioligand-binding studies revealed a reduced ability of GABA to enhance benzodiazepine binding, without changes in receptor density or affinity.

Conclusions:

• Chronic benzodiazepine exposure induces a functional subsensitivity to GABA in specific neuronal populations.
• This GABAergic subsensitivity, rather than altered receptor binding, may underlie reduced drug response.
• Pharmacological interventions targeting GABA sensitivity could be crucial for managing chronic benzodiazepine treatment.